Comparative In vitro cellular data alone are insufficient to predict clinical responses and guide the choice of BCR-ABL inhibitor for treating imatinib-resistant chronic myeloid leukemia.
作者信息
Laneuville Pierre, Dilea Clifford, Yin Ophelia Q P, Woodman Richard C, Mestan Jürgen, Manley Paul W
出版信息
J Clin Oncol. 2010 Apr 10;28(11):e169-71; author reply e172. doi: 10.1200/JCO.2009.26.4945. Epub 2010 Mar 1.
PMID:20194843
Abstract
摘要
Zotero 插件